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TI aim of the present study was to compare Serum levels of soluble IL-2R, CD4 serum levels of soluble forms of interleukin-2
receptor, CD4 and CD8, released by lymphocytes and CD8 in bronChial asthma
during activation of the immune system, in
patients with allergic bronchial asthma, with
those in healthy subjects. Significantly higher
levels of soluble IL-2R and soluble CD4 were G. Di I_orenzo,
found in patients with asthma compared with the G. Morii, F. Norrito, D. Cigna,
2 G. Candore
2
control group. In contrast, lower levels of soluble and
CD8 values were found in patients with asthma
compared to the control group. Significant corre-
lations were found for both sIL-2R and sCD4 lstituto di Medicina Interna e Geriatria, Universit and these two molecules, with lung function
measured as bronchial responsiveness to inhaled di Palermo, Via del Vespro, 141, 90127 Palermo,
methacholine. These results strengthen previous Italy; 21stituto di Patologia Generale, Universit& di
suggestions that in allergic bronchial asthma, Palermo, Corse Tukory 21 1, 90134 Palermo, Italy.
activation ofT cells plays a significant role in the
disease pathogenesis.
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Introduction immune system activation in response to an
allergen challenge. In particular, the levels of
It is well known that proliferation of T lym- serum sCD4 are raised in these diseases where
phocytes requires the interaction of a nominal there is a prominent role of helper T (Th)
antigen with both accessory cells and T lympho- cells.
-1 In the present paper, we studied the
cytes to produce the T cell growth factor inter- serum levels of sIL-2R, sCD4 and sCD8 as
leukin-2 (IL-2). Coincident with T cell activation markers of immune activation in asthmatic
and production of IL-2, T cells express the IL-2 patients with regard to their clinical status mea-
receptor (IL-2R) which is needed for T-cell pro- sured as bronchial responsiveness to inhaled
liferation in response to IL-2. Furthermore, acti- methacholine.
vated cells release a truncated form of the a
chain of IL-2R (sIL-2R). Various studies have
shown a strong association between serum sIL-2R Patients and Methods
levels and in vivo lymphocyte activation, and
have indicated that slL-2R production is directly Sample population: A total of 50 subjects were
proportional to cellular IL-2R expression, studied; 25 were patients with bronchial asthma
Because of the small numbers of B cells, NK (15 women and ten men, range 19- 54 years).
cells and monocytes expressing cellular IL-2R, it All patients had Parietaria sensitization and a
is conceivable that the majority of slL-2R is ela- baseline forced expiratory volume in i s (FEV1)
borated by activated T cells. Hence, serum slL-2R of at least 80% of predicted value, a provocative
levels can be used satisfactorily as a marker of T concentration of inhaled methacholine causing a
cell activation in vivo in patients with malignant, 20% fall in FEV1 (PC20) < 4 mg/ml. All patients
autoimmune and allergic disorders, as well as in studied used inhaled bronchodilatators when
subjects affected by systemic infectious diseases needed and had not been treated with disodium
or undergoing allograft rejection. Activation of T cromoglycate in the preceding 7 days. None of
cells not only leads to the release of slL-2R, but the patients were using oral or inhaled cortico-
also causes shedding of other glycoproteins steroids. Inhaled bronchodilator therapy was
related to T cell surface proteins, including withheld for 12h before the study. The controls
soluble forms of CD4 (sCD4) and CD8 (sCD8). consisted of 25 healthy adults (16 women and
Thus, increased amounts of the soluble forms of eleven men, range 20- 50 years). None of these
these glycoproteins may also be found in the subjects had a history of prolonged disease and
serum in states of increased activation of the none were ill or taking any drug at the time of
immune system.
1-7 the study. The patients and the control group
In allergic diseases, the increase of these were studied during the Parietaria pollen
serum soluble molecules is likely to indicate the season.
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Lung function measurements: FEV1 was meas-
ured with a Gould 2400 (Gould, Holland) auto-
mated system, taking the highest of three
successive measurements, provided the differ-
ence between measurements was within 100 ml.
A methacholine challenge was performed accord-
ing to the method of Chai et al.
1 Increased con-
centrations were administered with a Mefar
(Markos, Monza, Italy) nebulizer. After baseline
measurements of FEV1, subjects inhaled five
puffs of saline, since that was considered as the
control. Subjects then inhaled increasing con-
centrations of methacholine, ranging from 0.016
to 1.024mg/ml. FEV1 was measured 90s after
each concentration step. The provocation was
terminated when FEV1 fell by at least 20% from
the post-saline value.
Quantification of soluble molecules: The sera
were stored at -70C until assay. An enzyme
immunoassay test was used to quantify slL-2R,
sCD4 and sCD8. The assays were performed with
commercially available kits purchased from Cell-
free (T Cell Sciences, Inc., Cambridge, MA, USA).
All tests were performed according to the
manufacturer’s instructions as described prev-
iously.7’12’13 Detection limits in our laboratory for
slL-2R, sCD4 and sCD8 were 50 U/ml; 12 U/ml;
and 50 U/ml, respectively.
Statistical analysis.. All data were expressed as
means _+ S.D. Correlations were calculated by
linear regression. The values for the different
groups were compared with Student’s t-test.
Results
Patients with allergic asthma had significantly
higher levels of sIL-2R and sCD4 than the
normal controls (Table 1). As regards soluble
forms of CD8, levels were instead significantly
decreased in allergic patients compared with the
control group (Table 1). According to the
simultaneous increase of both sIL-2R and sCD4, a
significant correlation was shown between the
levels of these two molecules (Table 2).
To assess the role played by activated T lym-
phocytes in the pathogenesis of asthma, the con-
Table 1. Serum levels (mean ___
S.D.) of soluble IL-2R, CD4, and
CD8 in 25 normal controls and 25 asthmatic patients
Healthy subjects Patients
slL-2R 306 Jr- 24 1007 101
sCD4 29 3 76 -I- 4
sCD8 347 20 178 8
For a vs. b; c vs. d; e vs. f, p 0.0001
Table 2. Correlation between serum levels of CD4 and sCD8
and 1/-2R levels in 25 patients
Correlation coefficient p
sCD4 +0.613 0.0001
sOD8 -0.307 N.S.
centrations of their products in the peripheral
blood were correlated with changes in the objec-
tive measurements of airway obstruction. Figs. 1
and 2, respectively, demonstrate that bronchial
responsiveness (measured as response to inhaled
methacholine) correlated with the slL-2R and
sCD4 serum levels.
Discussion
The sIL-2R, sCD4 and sCD8 glycoproteins are
found in relatively large amounts in the circula-
tion and it is possible to obtain normal ranges
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FIG. 1. Correlation between serum slL-2R values (U/ml) and
inhaled concentration of methacholine (MCh) (mg/ml) that deter-
mined FEV1 fell by at least 20% from the post-saline value (see
Patients and Methods) in 25 asthmatic patients. (r---0.751;
p 0.00002).
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FIG. 2. Correlation between serum sCD4 values (U/ml) and
inhaled concentration of methacholine (MCh) (mg/ml) that deter-
mined FEV1 fell by at least 20% from the post-saline value (see
Patients and Methods)in 25 asthmatic patients. (r -0.833;
p 0.000001 ).
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for normal people with upper limits. Their blood
levels depend on the number of producing ceils
and on the number of molecules per cell, and
therefore their blood values represent an index
of the number and functional state of the produ-
cing cells. Thus, their release appears to be a
sensitive and quantitative marker of circulating
lymphocyte or mononuclear cell activation and
may also reflect immune activation in other
tissues or fluid compartments.
1-7
Much attention has been paid recently to the
inflammation infiltrate within the airways of
patients with asthma. Such inflammation may be
the basis of the bronchial hyperreactivity that is
the hallmark of this disease. Activated lym-
phocytes are prominent among the inflammatory
cells seen infiltrating the bronchi, and flow cyto-
metric analysis of cells in bronchoalveolar lavage
fluid from patients with asthma reveals increased
expression of CD25 by CD4 positive lympho-
cytes. The degree of activation of CD4 positive
lymphocytes correlates with the degree of bron-
chial hyperresponsiveness. In these cells, an acti-
vation of the interleukin-3, -4 and-5 and
granulocyte-macrophage colony-stimulating factor
gene cluster has been observed, a pattern com-
patible with predominant activation of the Th2
like cell population. Thus, bronchial inflamma-
tion in asthma should depend on the activation
of Th2 cells that elaborate proinflammatory cyto-
kines involved in the pathogenesis of tissue
damage.a,10,14
In asthmatic patients, various studies have
shown abnormalities of blood immunoregulatory
T cells (i.e., the reduction of CD8 cells with an
increase of the peripheral CD4/CD8 ratio and the
decreased capacity of concanavalin A-stimulated
cells to induce suppression in vitro). Activated
CD4 cells have been observed in the peripheral
blood of patients and the number of activated T
cells correlates with the airflow obstruction
assessed by peak flow measurements. Further-
more, the percentage of activated cells decreases
after therapy and clinical improvement. CD8 cells
show no evidence of activation. This CD4 cell
activation has been shown to be accompanied by
significantly elevated serum concentrations of
two proteins elaborated by such activated cells,
the cytokine interferon-7 and the slL-2R. A sig-
nifican relationship has been observed between
the slL-2R level and the degree of airflow
obstruction. These observations strongly suggest
that CD4 activation is relevant to the pathogen-
esis of asthma.8’1’15’16
Bronchial hyperresponsiveness is a prominent
feature in asthma. In our study we have observed
a significant inverse relationship between T cell
activation and bronchial responsiveness, mea-
sured as the responsiveness to inhaled metha-
choline in our subjects, confirming and
extending previous reports.1’15’6 We have quan-
tified CD4 activation by measuring soluble pro-
ducts released either by blood or by bronchial
lymphocytes. This has allowed us to demonstrate
a close correlation between the increase of sCD4
and slL-2R. Our results also demonstrate a sig-
nifican decrease of sCD8. On the whole, the
present findings strengthen the suggestion that in
asthma there is an imbalance of the CD4/CD8
ratio and that T helper lymphocytes are the prin-
cipal determinant for the development of bron-
chial hyperresponsiveness.8’4
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